Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial-Reference-Cited by-同舟云学术

Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial

Published:2010-07 Issue:9738 Volume:376 Page:346-354
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Mercier Jean-Christophe,Hummler Helmut,Durrmeyer Xavier,Sanchez-Luna Manuel,Carnielli Virgilio,Field David,Greenough Anne,Van Overmeire Bart,Jonsson Baldvin,Hallman Mikko,Baldassarre James

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Prospects for research in reproductive health and birth outcomes;Goldenberg;JAMA,2001

2. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia;Northway;N Engl J Med,1967

3. Bronchopulmonary dysplasia;Jobe;Am J Respir Crit Care Med,2001

4. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia;Stenmark;Annu Rev Physiol,2005

5. Inhibition of angiogenesis decreases alveolarization in the developing rat lung;Jakkula;Am J Physiol Lung Cell Mol Physiol,2000

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of pulmonary hypertension in infants;Expert Opinion on Orphan Drugs;2024-07-27

2. Strategies for the prevention of bronchopulmonary dysplasia;Frontiers in Pediatrics;2024-07-24

3. Establishment and Validation of a Risk Prediction Model for Non-Invasive Ventilation Failure After Birth in Premature Infants with Gestational Age < 32 Weeks;Lung;2024-07-03

4. Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial;The Lancet Respiratory Medicine;2024-07

5. Efficacy of inhaled nitric oxide in preterm infants ≤ 34 weeks: a systematic review and meta—analysis of randomized controlled trials;Frontiers in Pharmacology;2024-01-11